Updated hourlyHourly refreshFri, Jul 31, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · AI
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - Bitzero Holdings Inc. (NASDAQ: AIBZ) (CSE: AIBZ.U) (FSE: 000) ("Bitzero" or the "Company"), a provider of sustainable high-performance compute ("HPC") and AI data center infrastructure, announces that it has delivered the required notice under the Company's existing senior secured loan facility with a syndicate of lenders (the "Loan") of the Company's intention to prepay the outstanding obligations under the Loan.The Company expects...
Jul 31 · 11:00·mlpr-newsfile
Crypto
DUBAI, UAE, July 31, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, now supports six xStock assets as collateral. The move extends collateral eligibility across three of Bybit's core lending and margin products: Unified Trading Account...
Jul 31 · 11:00·PR Newswire
In the wire
New MEI Data Center Pathway Program will prepare Mississippians for high-demand careers supporting a $10 billion digital infrastructure investment in Meridian Compass Datacenters and Meridian Community College (MCC) launch Mississippi's first Mechanical, Electrical and Information...
Jul 31 · 11:00·PR Newswire
SaaS · Automotive
Broadens CREATE's delivery toolkit with access to Monash's novel LNP chemistries and next-generation targeting technologies. Enables rapid evaluation of diverse binder formats and cell-targeting strategies, accelerating development across multiple immune cell types and therapeutic...
Jul 31 · 11:00·PR Newswire
In the wire
London, United Kingdom--(Newsfile Corp. - July 31, 2026) - Digital Science today announced that Daniel Hook will take up the newly created role of Chief Scientific Officer at parent company Holtzbrinck Group, with Stephen Leicht, currently President, succeeding him as Chief Executive Officer effective 1 August 2026.Daniel Hook (left) has been appointed Chief Scientific Officer with Holtzbrinck Group; Stephen Leicht (right) becomes Digital Science's new CEO. Credit: Digital Science.To view an...
Jul 31 · 11:00·mlpr-newsfile
Finance
CALGARY, AB, July 31, 2026 /PRNewswire/ - Enbridge Inc. (Enbridge or the Company) (TSX: ENB) (NYSE: ENB) today reported second quarter 2026 financial results, reaffirmed its 2026 financial guidance and provided a quarterly business update. Highlights (All financial figures are unaudited...
Jul 31 · 11:00·PR Newswire
Healthcare
BAD HOMBURG, Germany, July 31, 2026--Fresenius Kabi, an operating company of Fresenius, announced today that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to the reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration.
Jul 31 · 11:00·mlpr-businesswire
Retail
CHICAGO and VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- RISE Dispensaries , an industry leading cannabis retail chain owned by Green Thumb Industries Inc . ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), today announced the opening of RISE Dispensary Hanover in Hanover, Pennsylvania. The new RISE store is located at 361 Eisenhower Drive, Hanover, PA 17331.
Jul 31 · 11:00·GlobeNewswire
Finance
Management to host conference call and webcast at 4:30 pm ET on that day
Jul 31 · 11:00·GlobeNewswire
Healthcare
Four-zone hospital EMR/HIS procurement, clinic CCMS expansion and the One Citizen, One Record strategy create a concentrated 2027-2029 opportunity for vendors able to prove national-scale execution
Jul 31 · 11:00·Newswire.com
Finance
Reports second quarter revenue of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(1.97) Reiterates plan to deliver up to 10% revenue growth in 2026 Improves 2026 GAAP operating expense outlook by approximately $0.2 billion from previous estimate and improves expected 2026 year-end cash balance to $4.7 - 5.2 billion Anticipates potential approval of Moderna's fifth product with the August 5th PDUFA date for mFLUSIVA, the Company's seasonal influenza vaccine candidate Announces that mRNA-1403, Moderna's norovirus vaccine candidate, did not meet statistical criteria for early success at the Phase 3 interim analysis and the Company is preparing to enroll an additional cohort
Jul 31 · 11:00·Newswire.com
In the wire
Jul 31 · 11:00·Newswire.com